top of page
Search


UK Delivers First NHS-Commissioned Brain Gene Therapy to Youngest Patient
Published on Independent UK / LinkedIn via Spencer Knight A three-year-old girl with a rare disorder called AADC deficiency has become...
Jun 25, 2025


International Coalition Aims to Double CAR‑T Access by 2030
Published on CAR T Vision (via CAR T Vision Coalition website) A new international coalition, CAR T Vision, has launched with a bold...
Jun 21, 2025


Sarepta Pauses Elevidys for Older Duchenne Patients After Second Liver-Related Death
Published on The Associated Press Sarepta has suspended shipments of Elevidys and paused a trial arm after a second non-ambulatory...
Jun 18, 2025


Eli Lilly Acquires Verve for $1.3B to Boost In Vivo Gene Editing for Heart Disease
Published on Spencer Knight via LinkedIn Eli Lilly has announced plans to acquire Verve Therapeutics in a deal worth up to $1.3 billion....
Jun 17, 2025


Supernus Acquires Sage Therapeutics for $795M to Expand Neuropsychiatry Pipeline
Published on Spencer Knight via LinkedIn Supernus Pharmaceuticals is acquiring Sage Therapeutics in a $795 million all-cash deal....
Jun 17, 2025


BioNTech to Acquire CureVac for $1.25B in All-Stock mRNA Oncology Deal
Published on Spencer Knight via LinkedIn BioNTech has signed a definitive agreement to acquire CureVac in an all-stock transaction valued...
Jun 17, 2025


Barcelona-Based SpliceBio Raises €119M to Target Stargardt Disease
Published on Spencer Knight via LinkedIn SpliceBio has secured €119 million in Series B funding, the largest ever for a biotech in...
Jun 17, 2025


Mother of Two Enters Remission After TIL Cell Therapy for Stage 4 Melanoma
Published on Spencer Knight via LinkedIn Missy Christy had already beaten cancer once. Then, as a new mother, she faced it again—this...
Jun 17, 2025


CAR-T and Dendritic Cell Therapies Show Promise in Tackling Glioblastoma
Published on Spencer Knight via LinkedIn Glioblastoma remains one of the deadliest brain cancers with limited treatment options. Two new...
Jun 17, 2025


Sanofi Acquires Blueprint Medicines for $9.1B, Strengthens Rare Immunology Portfolio
Published on Spencer Knight via LinkedIn Sanofi has announced a definitive agreement to acquire Blueprint Medicines in a $9.1 billion...
Jun 17, 2025


Australian CAR T Trial Puts Lupus Into Remission for Young Woman in Historic First
Published on Spencer Knight via LinkedIn Lani Watson, 32, lived with severe lupus that left her in constant pain and unable to walk. In a...
Jun 17, 2025


Sanofi Acquires Vigil Neuroscience for $470M, Expands Alzheimer’s Pipeline
Published on Spencer Knight via LinkedIn Sanofi has agreed to acquire Vigil Neuroscience in a $470 million deal, reinforcing its...
Jun 17, 2025


Gene Therapy Frees Patient from 29 Years of Haemophilia B Treatment
Published on Spencer Knight via LinkedIn Elliott Collins, 34, lived with haemophilia B for nearly three decades, relying on frequent...
Jun 17, 2025


2025 Set to Be a Breakout Year for siRNA as Funding and FDA Wins Pile Up
Published on Spencer Knight via LinkedIn siRNA therapies are seeing renewed momentum, with major investments and regulatory wins...
Jun 17, 2025


Baby KJ Becomes First Patient to Receive Fully Personalized CRISPR Therapy
Published on Spencer Knight via LinkedIn At just nine months old, KJ was diagnosed with CPS1 deficiency, a rare metabolic disorder...
Jun 17, 2025


$240M+ in Deals and 1 New Approval Mark CGT Momentum Surge at ASGCT
Published on Spencer Knight via LinkedIn A packed week at ASGCT brought a wave of new CGT developments totaling over $240 million in...
Jun 17, 2025


GSK Acquires Efruxifermin for $2B, Targeting MASH and Liver Fibrosis
Published on Spencer Knight via LinkedIn GSK is acquiring efruxifermin alfa from Boston Pharmaceuticals for up to $2 billion, including...
Jun 17, 2025


HAON Life Sciences Secures €10.7M to Advance Allogeneic Cell Therapy for Infant Brain Injury
Published on Spencer Knight via LinkedIn HAON Life Sciences, a Dublin-based biotech startup, has received €10.7 million from Ireland’s...
Jun 17, 2025


CRISPR Eliminates Stage 4 Colon Cancer in Breakthrough First-in-Human Trial
Published on Spencer Knight via LinkedIn Emma Dimey was diagnosed with stage 4 colorectal cancer at just 23. After 11 years of failed...
Jun 17, 2025


Gene Therapy Saves 4-Year-Old with Rare Immune Disorder Once Considered Fatal
Published on Spencer Knight via LinkedIn Eisa Hussain was diagnosed as an infant with leukocyte adhesion deficiency type 1 (LAD-1), a...
Jun 17, 2025
bottom of page
